Congenital nystagmus is a sign not a diagnosis. One of the diagnoses causing congenital nystagmus is Leber Congenital Amaurosis. With the advent of FDA approved treatment for one type of Leber Congenital Amaurosis and clinical trials for other types, it is imperative that pediatric ophthalmologists make this diagnosis in a timely manner. This talk will present cases and the workup which revealed the diagnosis, give an update on results of gene therapy trials, and describe how to navigate websites and other resources to determine which genetic eye disorders currently have clinical trials in the pipeline.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
- Community Eye Care Professionals
- Medical students
- Graduate students
- Postdoctoral Fellows
- Vision Scientists
At the end of this session, I will be able to:
- Understand how to find gene therapy trials for specific diagnoses/patients
- Be able to name 3 pediatric ophthalmology conditions with current gene therapy treatment or clinical trials
- Be able to plan an appropriate workup for children with congenital nystagmus
All persons in control of content has no relevant financial relationships to disclose with the exception of:
|Arlene Drack, MD||Retropin||Speaker|
|Vision for Tomorrow|
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.